Acute Myeloid Leukemia with MYC Rearrangement and JAK2 V617F Mutation

Little is known about MYC dysregulation in myeloid malignancies, and we can find no published studies that have evaluated MYC protein expression in primary cases of myelodysplastic syndromes (MDS) or acute myeloid leukemias (AML). We describe the clinical, morphologic, immunophenotypic, cytogenetic,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Genet
Glavni autori: Ohanian, Maro, Bueso-Ramos, Carlos, Ok, Chi Young, Lin, Pei, Patel, Keyur, Alattar, Mona Lisa, Khoury, Joseph D., Rozovski, Uri, Estrov, Zeev, Huh, Yang O., Cortes, Jorge, Abruzzo, Lynne V.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4835801/
https://ncbi.nlm.nih.gov/pubmed/26382622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cancergen.2015.06.004
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items